Building Blocks

ABX464 is a monoclonal antibody that targets bacterial translocation. It has been shown to have clinical efficacy in preventing the recurrence of inflammatory bowel disease. ABX464 binds to the M2 phenotype of macrophages and blocks the binding of chemoattractant protein to its receptor, leading to decreased inflammation and less bacterial translocation. It also prevents HIV infection by blocking viral attachment to CD4 cells and inhibiting HIV-1 replication.

Versatile small molecule scaffold

Versatile small molecule scaffold

3-Aminopyrrolidin-2-one hcl is an antibiotic that is used to treat tuberculosis. It inhibits the enzyme transacylase, which catalyses the conversion of L-lysine into L-pipecolic acid in bacteria. This antibiotic has been shown to be effective against Mycobacterium tuberculosis and Mycobacterium avium complex. 3-Aminopyrrolidin-2-one hcl has a broad spectrum of activity against gram positive and gram negative bacteria, but it is not active against acid-fast bacteria.

Versatile small molecule scaffold

Versatile small molecule scaffold

1-Hydroxycyclopentane-1-carbonitrile is a monomer that is hydrolyzed to form benzoin and cyanohydrins. It can be used in the production of scifinder as a monomer or dimerizer.

Please enquire for more information about (R)-4-N-Boc-2-hydroxymethyl-piperazine including the price, delivery time and more detailed product information at the technical inquiry form on this page

Boc-His(Trt)-OH is a chemical compound that has been used in the laboratory to study uptake and binding of compounds. It is stable in complex with albumin, which has led to its use as a model system for studying hepatic steatosis. This chemical can be synthesized by solid-phase synthesis with trifluoroacetic acid and polypeptide synthesis. FT-IR spectroscopy has been used to characterize Boc-His(Trt)-OH, revealing its chemical diversity.

2,4-Dibromopyridine is a brominated derivative of pyridine. It is synthesized through the substitution of two bromine atoms for two hydrogens on the pyridine ring. This synthesis can be achieved by disubstitution or cross-coupling reactions. The reaction products are nucleophilic and react with electrophiles to produce substitution products. The reaction mechanism is thought to involve a six-membered transition state, which has been observed using X-ray absorption spectroscopy.

Leu-Leu-Leu-OH is a pentapeptide that is used in cancer treatment to inhibit the growth of cancer cells. It prevents the production of proteins and, as a result, cell division. Leu-Leu-Leu-OH has been shown to be effective against tumor cells with an antibody that binds to the surface of cells. The monoclonal antibody is taken up by the cancer cells through receptor mediated endocytosis, which leads to inhibition of protein synthesis and cell death.

Metal-chelating agent

5-Bromo-2-iodopyridine is an antibiotic that is used to treat bacterial infections. It has been shown to inhibit the growth of bacteria by binding to the 50S ribosomal subunit. This drug also has a toxic effect on respiratory system cells, which may be due to its ability to induce apoptosis. 5-Bromo-2-iodopyridine interacts with DNA in a triazine ring and inhibits bacterial growth by inhibiting protein synthesis. The drug binds to the 50S ribosomal subunit at a site that is different from that of rifampin and other antibiotics. The reaction is catalyzed by palladium at high temperatures and takes place in organic solvents such as chloroform or benzene. This synthetic process can be made more efficient by using inexpensive starting materials, such as bromine, iodine, and acetone, rather than expensive starting materials like platinum or gold salts.

2-Bromo-3,3,3-trifluoro-1-propene is a chemical compound that has been synthesized in an asymmetric reaction. The reactant is bromopropane and the product is 2,2,2-trifluoropropene. The methylene group on the propene molecule is activated by the nucleophilic attack of a fluoride ion from hydrogen fluoride to form a cavity with a highly strained bond. The kinetic study of this reaction revealed that the activation energy for the reaction is 42 kJ/mol. Palladium-catalyzed coupling reactions are catalyzed by palladium and require nonpolar solvents such as toluene or dichloromethane. This type of reaction has been shown to be exothermic with an isolated yield of 1%.

1-Bromo-4-iodobenzene is an aryl halide that can be synthesized by the cross coupling of ethyl formate and hydrochloric acid. This compound is useful in analytical applications, such as chromatographic methods, due to its high solubility in organic solvents. It is also used in synthetic procedures for the preparation of other aryl halides. 1-Bromo-4-iodobenzene has been used to synthesize calcium carbonate via the Suzuki coupling reaction with sodium salts, which are nucleophiles. The carbonyl group on this molecule reacts with the nucleophile, forming an alkyl group and a metal salt. Transfer reactions involving these salts can produce other products with different functional groups.

4-Chloro-8-quinolinol is a quinoline derivative that has been shown to have pharmacological effects. It is used in the synthesis of other compounds, such as 5-chloro-8-hydroxyquinoline, which is used in the treatment of cancer. 4-Chloro-8-quinolinol can also be prepared by oxidizing 5,6,7,8 tetrachloroquinoline with chlorine and ammonia. The photophysical properties of this compound are analogous to those of benzothiazole derivatives. The fluorescence emission spectrum ranges from 360 nm to 450 nm with a maximum at 390 nm and emission intensity at 350 nm. This compound exhibits fungitoxicity against Penicillium notatum and Aspergillus fumigatus.

(-)-Corey lactone diol is a synthetic compound that is soluble in organic solvents. It is used for the synthesis of carbocyclic nucleosides, which are analogs of pyrimidine nucleosides. (-)-Corey lactone diol has been shown to inhibit cholesterol synthesis and the synthesis of alkene. (-)-Corey lactone diol also shows anti-inflammatory properties, which may be due to its inhibition of prostaglandin synthesis.